OS Therapies Incorporated
OSTX
$1.72
-$0.03-1.44%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -212.13% | -223.70% | -148.55% | -121.18% | -52.64% |
| Total Depreciation and Amortization | 17,300.00% | 12,864.29% | 17,007.14% | 2,338.30% | -41.67% |
| Total Amortization of Deferred Charges | -22.38% | -27.22% | -100.00% | -85.17% | -29.78% |
| Total Other Non-Cash Items | 994.28% | 1,227.17% | -- | -- | -21.10% |
| Change in Net Operating Assets | 2,097.78% | 7,117.80% | 4,003.17% | -31.37% | -142.50% |
| Cash from Operations | -52.35% | -95.52% | -122.93% | -253.49% | -213.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.66% | -- | -- | -- | -- |
| Cash from Investing | -68.66% | -- | -- | -- | -- |
| Total Debt Issued | 103.89% | -- | -100.00% | -100.00% | -72.17% |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 114.98% | 50.37% | 19.87% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -99.99% | -82.59% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 258.24% | -- | 100.00% | 905.70% | 155.24% |
| Cash from Financing | 3.60% | -26.11% | 75.41% | 344.31% | 342.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.53% | -195.80% | -99.00% | 5,836.62% | 1,225.36% |